Hormone therapy and recurrence of venous thromboembolism among postmenopausal women

Abstract

Oral but not transdermal estrogens are associated with a higher risk of recurrent VTE among postmenopausal women. This result provides further epidemiological evidence that transdermal estrogens may be safe with respect to VTE risk.